- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 471/04 - Ortho-condensed systems
Patent holdings for IPC class C07D 471/04
Total number of patents in this class: 25810
10-year publication summary
|
1362
|
1531
|
1559
|
1652
|
1598
|
1713
|
1876
|
1929
|
1758
|
497
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bristol-myers Squibb Company | 4809 |
529 |
| Merck Patent GmbH | 5662 |
338 |
| Merck Sharp & Dohme LLC | 3708 |
317 |
| Novartis AG | 10350 |
310 |
| F. Hoffmann-La Roche AG | 7828 |
310 |
| Janssen Pharmaceutica N.V. | 3235 |
303 |
| Takeda Pharmaceutical Company Limited | 2719 |
301 |
| Hoffmann-La Roche Inc. | 3679 |
273 |
| Boehringer Ingelheim International GmbH | 4535 |
265 |
| Incyte Corporation | 1048 |
264 |
| Gilead Sciences, Inc. | 2180 |
258 |
| Amgen Inc. | 4337 |
236 |
| Genentech, Inc. | 4061 |
222 |
| Dana-Farber Cancer Institute, Inc. | 2630 |
201 |
| Pfizer Inc. | 3362 |
195 |
| AstraZeneca AB | 2839 |
176 |
| Abbvie Inc. | 1847 |
171 |
| Bayer AG | 3431 |
168 |
| Bayer Pharma AG | 1028 |
162 |
| Vertex Pharmaceuticals Incorporated | 1602 |
151 |
| Other owners | 20660 |